Cannabics PharmaceuticalsCNBX 
$0.010.00%24h
0.00%24h
Global rank
Market cap$88.25K
Change 7d0.00%
YTD Performance0.00%
SP500 benchmarkUnderperform
P/E-0.02
P/S0.22
Revenue$410.17K
Earnings-$3.71M
Dividend yield-
Main Sector
Healthcare
Category
EPS for Cannabics Pharmaceuticals (CNBX)
Cannabics Pharmaceuticals has an EPS of $-0.42. In 2022, the company made an earnings per share (EPS) of $-3.59. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for CNBX
-
Value:-
EPS history for Cannabics Pharmaceuticals from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$0.42 | -88.30% |
| 2022 | -$3.59 | 49.58% |
| 2021 | -$2.40 | -80.00% |
| 2020 | -$12.00 | - |
View the highest EPS stocks
